Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:3112819rdf:typepubmed:Citationlld:pubmed
pubmed-article:3112819lifeskim:mentionsumls-concept:C0229906lld:lifeskim
pubmed-article:3112819lifeskim:mentionsumls-concept:C0012471lld:lifeskim
pubmed-article:3112819lifeskim:mentionsumls-concept:C1521970lld:lifeskim
pubmed-article:3112819lifeskim:mentionsumls-concept:C0441472lld:lifeskim
pubmed-article:3112819lifeskim:mentionsumls-concept:C0180499lld:lifeskim
pubmed-article:3112819lifeskim:mentionsumls-concept:C1301808lld:lifeskim
pubmed-article:3112819lifeskim:mentionsumls-concept:C2348519lld:lifeskim
pubmed-article:3112819pubmed:issue2lld:pubmed
pubmed-article:3112819pubmed:dateCreated1987-9-4lld:pubmed
pubmed-article:3112819pubmed:abstractTextIn dogs, PGF2 alpha injected into the Arteria facialis increases the local blood flow and microvascular permeability accompanied by an important increase of lymph and salivary flow. The results of our investigations allowed us to speculate that PGF2 alpha may be an important component of the regulatory mechanism underlying salivary secretion.lld:pubmed
pubmed-article:3112819pubmed:languageenglld:pubmed
pubmed-article:3112819pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3112819pubmed:citationSubsetIMlld:pubmed
pubmed-article:3112819pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3112819pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3112819pubmed:statusMEDLINElld:pubmed
pubmed-article:3112819pubmed:issn1011-6206lld:pubmed
pubmed-article:3112819pubmed:authorpubmed-author:DandelMMlld:pubmed
pubmed-article:3112819pubmed:authorpubmed-author:SzabóHHlld:pubmed
pubmed-article:3112819pubmed:authorpubmed-author:LàszlòJJlld:pubmed
pubmed-article:3112819pubmed:issnTypePrintlld:pubmed
pubmed-article:3112819pubmed:volume24lld:pubmed
pubmed-article:3112819pubmed:ownerNLMlld:pubmed
pubmed-article:3112819pubmed:authorsCompleteYlld:pubmed
pubmed-article:3112819pubmed:pagination97-104lld:pubmed
pubmed-article:3112819pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:3112819pubmed:meshHeadingpubmed-meshheading:3112819-...lld:pubmed
pubmed-article:3112819pubmed:meshHeadingpubmed-meshheading:3112819-...lld:pubmed
pubmed-article:3112819pubmed:meshHeadingpubmed-meshheading:3112819-...lld:pubmed
pubmed-article:3112819pubmed:meshHeadingpubmed-meshheading:3112819-...lld:pubmed
pubmed-article:3112819pubmed:meshHeadingpubmed-meshheading:3112819-...lld:pubmed
pubmed-article:3112819pubmed:meshHeadingpubmed-meshheading:3112819-...lld:pubmed
pubmed-article:3112819pubmed:meshHeadingpubmed-meshheading:3112819-...lld:pubmed
pubmed-article:3112819pubmed:meshHeadingpubmed-meshheading:3112819-...lld:pubmed
pubmed-article:3112819pubmed:meshHeadingpubmed-meshheading:3112819-...lld:pubmed
pubmed-article:3112819pubmed:meshHeadingpubmed-meshheading:3112819-...lld:pubmed
pubmed-article:3112819pubmed:meshHeadingpubmed-meshheading:3112819-...lld:pubmed
pubmed-article:3112819pubmed:meshHeadingpubmed-meshheading:3112819-...lld:pubmed
pubmed-article:3112819pubmed:meshHeadingpubmed-meshheading:3112819-...lld:pubmed
pubmed-article:3112819pubmed:articleTitleCharacteristic features concerning the action of prostaglandin F2 alpha (PGF2 alpha) on the microvascular territories drained by truncus jugularis.lld:pubmed
pubmed-article:3112819pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:3112819pubmed:publicationTypeComparative Studylld:pubmed